BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38457659)

  • 1. Assessment of DNA/RNA Deregulation in Cancer Using
    Chiu CH; Yang DJ; Liou YC; Chang WC; Yu TH; Chung MC; Lee YC; Chen IJ; Wang PY; Lin CP; Tsay HJ; Yeh SH
    Cancer Biother Radiopharm; 2024 Mar; ():. PubMed ID: 38457659
    [No Abstract]   [Full Text] [Related]  

  • 2. Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors.
    Yeh SH; Chang WC; Hsu SM; Lin MH; Chung MC; Ke CS; Lee YC; Hwang CJ; Yang DJ
    Cancer Biother Radiopharm; 2022 Feb; 37(1):30-40. PubMed ID: 34491835
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and Biological Evaluation of Novel
    Song X; Gan Q; Zhang X; Zhang J
    Mol Pharm; 2019 Oct; 16(10):4213-4222. PubMed ID: 31424939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
    Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
    Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [
    Facca VJ; Al-Saden N; Ku A; Reilly RM
    Mol Imaging Biol; 2021 Aug; 23(4):495-504. PubMed ID: 33479914
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ferro-Flores G; Ocampo-García B; Cruz-Nova P; Luna-Gutiérrez M; Bravo-Villegas G; Azorín-Vega E; Jiménez-Mancilla N; Michel-Sánchez E; García-Pérez O; Lara-Almazán N; Santos-Cuevas C
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel small
    Liang Z; Hu X; Hu H; Wang P; Cai J
    Front Oncol; 2022; 12():1017737. PubMed ID: 36387113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
    Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo imaging of breast tumors by a
    Kang L; Huo Y; Wang RF; Zhang CL; Yan P; Xu XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):326-330. PubMed ID: 29643534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
    Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
    J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of
    Gan Q; Song X; Zhang X; Zhang J
    Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
    Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
    J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tc-99m-tamoxifen: A novel diagnostic imaging agent for estrogen receptor-expressing breast cancer patients.
    Chhabra A; Sharma U; Kumar R; Laroiya I; Bhatia A; Chadha V; Vatsa R; Upadhyay D; Kaur K; Bal A; Singh G; Mittal BR; Shukla J
    Diagn Interv Radiol; 2022 May; 28(3):275-284. PubMed ID: 35748212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Imaging of Tumor PD-L1 Expression Using [
    Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
    Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tyrosine-based radiotracer 99mTc-N4-Tyrosine for breast cancer imaging.
    Kong FL; Ali MS; Rollo A; Smith DL; Zhang Y; Yu DF; Yang DJ
    J Biomed Biotechnol; 2012; 2012():671708. PubMed ID: 22496612
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.